RU EN

Mon.-Fri.: 1000-1900

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

«A.Zalesov & Partners» Patent & Law Firm is a full-service IP law firm that gives IP advice, handles litigation (patents, trademarks and designs) and provides services in patent, design and trademark prosecution in the Russian Patent and Trademark Office and the Eurasian Patent Office. We handle our international clients' patent and trademark portfolios (including Madrid and Hague Systems of trademark and design registration) in Russia as well as in the neighboring countries, including the countries of the Eurasian Custom and Economic Union. Twenty years of experience in conducting patent and trademark disputes between leading players in the relevant markets in Russia and abroad enables us to give verified practical advice on IP protection, invalidation and enforcement strategy.

 

In focus

Legal costs incurred by a client of «A.Zalesov & Partners» (ZTG Group) in a dispute over the termination of trademark protection due to non-use were recovered from a third party that abused its procedural rights

On October 21, 2026, the Intellectual Property Court approved the settlement agreement in case SIP-251/2025 and, by the same ruling, resolved the issue of recovering the legal costs of «A.Zalesov & Partners» client from the third party, since, had this party properly performed its procedural obligations, a significant portion of the legal costs would not have been incurred, and there would have been no need for this party to file an application for reconsideration of the court case based on new circumstances. This is a rare case of the application of Article 111 of the Arbitration Procedure Code of the Russian Federation, when legal costs are recovered from a party other than the losing party.

02.11.2026

«A.Zalesov & Partners» succeeded in invalidating one of the Eurasian patents related to the anti-cancer drug daratumumab

On May 26, 2026, Rospatent upheld the objection of BIOCAD JSC and decided to completely terminate the validity of Eurasian patent for invention No. 34877, related to the antitumor drug daratumumab, of GENMAB A/S (Denmark), in the territory of the Russian Federation.

02.11.2026

ZTG at the III All-Russian Tourism Congress «Gates of the Russian North» in Kirov

Irina Ozolina held a seminar on «Promotion, Protection and Use of Regional Brands» at the 3rd All-Russian Tourism Congress «Gates of the Russian North» in Kirov, which attracted maximum attention from participants thanks to its perfect balance of legal theory and real business cases.

15.10.2026